导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -25.95% | 332/354 |
| 近一周 | -1.79% | 81/362 |
| 近一月 | -6.00% | 256/362 |
| 近一季 | -5.26% | 191/362 |
| 近半年 | -17.16% | 335/358 |
| 近一年 | -32.80% | 322/349 |
| 近两年 | 9.83% | 257/314 |
| 近三年 | 10.33% | 184/246 |
| 成立以来 | -1.56% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-17.67% 331/360 |
-14.23% 326/366 |
- - |
- - |
| 2025 | 29.16% 39/358 |
22.90% 26/340 |
-3.48% 310/348 |
26.32% 29/354 |
-13.80% 257/358 |
| 2024 | 21.93% 80/329 |
-2.32% 189/280 |
9.00% 34/310 |
28.95% 56/318 |
-11.19% 303/329 |
| 2023 | -10.62% 159/275 |
6.30% 62/205 |
-14.30% 204/230 |
-1.71% 21/262 |
-0.19% 154/276 |
| 2022 | -22.75% 114/201 |
-17.48% 113/153 |
6.39% 50/164 |
-24.09% 140/189 |
15.92% 41/202 |
| 2021 | -38.16% 95/150 |
-1.53% 251/312 |
-3.64% 295/328 |
-27.30% 318/358 |
-10.35% 128/151 |
| 2020 | 50.09% 1/103 |
-5.39% 79/280 |
28.73% 45/295 |
15.20% 14/299 |
6.97% 172/305 |
| 2019 | - - |
- - |
-6.40% 248/267 |
-4.51% 218/253 |
19.28% 4/266 |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 广发中证香港创新药ETF(QDII) | 1.2744 | 27.49% |
| 广发道琼斯石油指数美元现汇A | 0.4802 | 27.44% |
| 广发道琼斯石油指数美元现汇C | 0.4718 | 27.38% |
| 广发道琼斯石油指数(QDII-LOF)美元现汇E | 0.4729 | 27.33% |
| 广发道琼斯石油指数人民币A | 3.2498 | 26.68% |
| 广发道琼斯石油指数人民币C | 3.1927 | 26.58% |
| 广发道琼斯石油指数(QDII-LOF)人民币E | 3.2003 | 26.55% |
| 广发中证香港创新药ETF发起式联接(QDII)C | 1.3286 | 26.01% |
| 富国标普石油天然气勘探及生产精选行业ETF(QDII) | 1.4105 | 25.68% |
| 汇添富恒生生物科技ETF(QDII) | 1.1055 | 25.31% |
| 易方达中证海外50ETF联接美元A VS. 建信富时100指数(QDII)人民币A(539003) |